This AI cloud infrastructure provider has jumped more than 150% in 2025, and its stunning growth rate suggests that more upside could be in the cards.

Tempus AI TEM stock saw a positive improvement to its Relative Strength (RS) Rating on Thursday, rising from 66 to 78. Please ...

Tempus AI’s TEM stock has surged nearly 13% since its second-quarter 2025 earnings release. The quarter saw strong top-line ...

Bioventus Inc. (NASDAQ:BVS) is one of the best medical device stocks to buy according to analysts. On August 7, Craig-Hallum ...

The stock soared after investors heard that update. Exponential revenue increases are being driven by its burgeoning AI infrastructure services. Just as importantly for investors, Nebius has a solid ...

Ballie Gifford is one of the best growth investors in the world and has been almost form inception. The firm was founded in ...

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting ...

Tempus AI (NASDAQ:TEM), a technology company that applies artificial intelligence to precision diagnostics and healthcare data, reported its Q2 2025 earnings on August 8, 2025. Th ...

Tempus AI achieves strong revenue growth and beats expectations, but ongoing losses and execution risks temper enthusiasm.

In a report released today, Rachel Vatnsdal from J.P. Morgan maintained a Hold rating on Tempus AI, Inc. Class A, with a price target of $60.00. The company’s shares closed last Friday at $60.87. Take ...

Tempus AI, Inc. (NASDAQ:TEM) investors will be delighted, with the company turning in some strong numbers with its latest results. Results overall were solid, with revenues arriving 5.7% better than ...